Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Teva Pharmaceutical Industries Insider Sold Shares Worth $1,928,729, According to a Recent SEC Filing

Teva Pharmaceutical Industries Insider Sold Shares Worth $1,928,729, According to a Recent SEC Filing

MT newswireMT newswire2026/11/06 20:16
04:16 PM EST, 11/06/2026 (MT Newswires) -- Mark Sabag, Executive Vice President, International Markets Commercial, on November 05, 2026, sold 46,000 shares in Teva Pharmaceutical Industries (TEVA) for $1,928,729. Following the Form 4 filing with the SEC, Sabag has control over a total of 80,760 ordinary shares of the company, with 80,760 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/818686/000119312526451814/xslF345X05/ownership.xml
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!